Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pds Biotechnology Corp.

Clinical trials sponsored by Pds Biotechnology Corp., explained in plain language.

PDS Biotechnology Corporation PDSB NASDAQ

A clinical-stage biotech developing immunotherapies for cancer and infectious diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

Experimental combo targets HPV-Driven head and neck tumors

Disease control Completed

This Phase 2 trial tested a combination of two immunotherapies—PDS0101 and pembrolizumab (Keytruda)—in 95 adults with HPV16-positive head and neck cancer that had returned or spread. The goal was to see if the combo could shrink tumors or slow the disease. Participants received b…

Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC